Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Murphy

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Irish Medical Journal|August 7, 2013
Case 1: chronic thromboembolic pulmonary hypertension (CTEPH)D T Murphy, D M Murphy, J G Murray, et al.
Irish Medical Journal|August 6, 2013
Case 2: SilicosisD T Murphy, D M Murphy, J G Murray, et al.
The American Review of Respiratory Disease|January 1, 1987
Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasiiC H Ahn, R J Wallace, L C Steele, et al.
Brain Research|November 10, 1980
A study of the quantal (all-or-none) change in reflex latency produced by opiate analgesicsJ D Levine, D T Murphy, D Seidenwurm, et al.
Lancet (London, England)|December 20, 1986
A non-invasive method for measuring cardiac output: the effect of Christmas lunchA J Cowley, K Stainer, D T Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complexD E Griffith, B A Brown, P Cegielski, et al.
The American Review of Respiratory Disease|September 1, 1986
A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complexC H Ahn, S S Ahn, R A Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1996
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virusD E Griffith, B A Brown, W M Girard, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patientsR J Wallace, B A Brown, D E Griffith, et al.
The Journal of Infectious Diseases|July 4, 1998
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patientsD E Griffith, B A Brown, D T Murphy, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Irish Medical Journal|August 7, 2013
Case 1: chronic thromboembolic pulmonary hypertension (CTEPH)D T Murphy, D M Murphy, J G Murray, et al.
Irish Medical Journal|August 6, 2013
Case 2: SilicosisD T Murphy, D M Murphy, J G Murray, et al.
The American Review of Respiratory Disease|January 1, 1987
Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasiiC H Ahn, R J Wallace, L C Steele, et al.
Brain Research|November 10, 1980
A study of the quantal (all-or-none) change in reflex latency produced by opiate analgesicsJ D Levine, D T Murphy, D Seidenwurm, et al.
Lancet (London, England)|December 20, 1986
A non-invasive method for measuring cardiac output: the effect of Christmas lunchA J Cowley, K Stainer, D T Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complexD E Griffith, B A Brown, P Cegielski, et al.
The American Review of Respiratory Disease|September 1, 1986
A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complexC H Ahn, S S Ahn, R A Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1996
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virusD E Griffith, B A Brown, W M Girard, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patientsR J Wallace, B A Brown, D E Griffith, et al.
The Journal of Infectious Diseases|July 4, 1998
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patientsD E Griffith, B A Brown, D T Murphy, et al.
Pageof 2